Sustained hemodynamic response to flosequinan in patients with heart failure receiving angiotensin-converting enzyme inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sustained hemodynamic response to flosequinan in patients with heart failure receiving angiotensin-converting enzyme inhibitors

Published:1993-10 Issue:4 Volume:22 Page:963-967
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Gottlieb Stephen S.,Kukin Marrick L.,Penn Joshua,Fisher Michael L.,Cines Michelle,Medina Norma,Yushak Madeline,Taylor Mary,Packer Milton

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Future directions in vasodilator therapy for heart failure;Cohn;Am Heart J,1991

2. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure;Cohn;N Engl J Med,1991

3. Hemodynamic effects of BTS-49465, a new long-acting systemic vasodilator drug, in patients with severe congestive heart failure;Kessler;Am Heart J,1987

4. Exercise capacity, hemodynamic, and neurohormonal changes following acute and chronic administration of flosequinan in chronic congestive heart failure;Riegger;Cardiovasc Drugs Ther,1990

5. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure;Cavero;J Am Coll Cardiol,1992

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials;European Journal of Heart Failure;2019-08-13

2. Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure;Circulation;2018-09-04

3. Long-Term Effects of Flosequinan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure;JACC: Heart Failure;2017-06

4. Drug Approval Process for Acute Heart Failure Syndrome in the United States;Acute Heart Failure;2008

5. Why do phase III trials of promising heart failure drugs often fail? the contribution of “regression to the truth”;Journal of Cardiac Failure;2003-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3